Zobrazeno 1 - 10
of 35
pro vyhledávání: '"简伟明"'
Publikováno v:
Journal of Food Safety & Quality; Nov2024, Vol. 15 Issue 22, p318-324, 7p
Publikováno v:
Acta Edulis Fungi; 2023, Vol. 30 Issue 6, p101-109, 9p
Autor:
Ling-YiXiao, 蕭綾儀
105
More than 95% chronic myeloid leukemia (CML) patients carry the constitutively activated tyrosine kinase, BCR-ABL fusion protein. Therefore, tyrosine kinase inhibitors (TKIs) are designed for CML treatment. However, some patients have no res
More than 95% chronic myeloid leukemia (CML) patients carry the constitutively activated tyrosine kinase, BCR-ABL fusion protein. Therefore, tyrosine kinase inhibitors (TKIs) are designed for CML treatment. However, some patients have no res
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/pdph3y
Autor:
Yu-LinChen, 陳玉霖
104
Differentiation-inducing therapy is used to treat patients who have undifferentiated cancer, such as leukemia. During induction stimulation, leukemia cell differentiation is always observed together with cell death. Reactive oxygen species (
Differentiation-inducing therapy is used to treat patients who have undifferentiated cancer, such as leukemia. During induction stimulation, leukemia cell differentiation is always observed together with cell death. Reactive oxygen species (
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/4zx8d2
Autor:
Ka-HeiCheong, 張嘉熙
103
Normal platelet production is largely affected by the megakaryocyte (MKs) differentiation. Abnormal differentiation process could result in clinical disorders like thrombocytopenia and essential thrombocythemia. Thus, the study of how megaka
Normal platelet production is largely affected by the megakaryocyte (MKs) differentiation. Abnormal differentiation process could result in clinical disorders like thrombocytopenia and essential thrombocythemia. Thus, the study of how megaka
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/8ra85f
Autor:
Wei-ShanChang, 張瑋珊
103
Some types of acute myeloid leukemia (AML) can be treated with all-trans retinoic acid (ATRA), which induces cell differentiation, in combination with other chemotherapeutics. However, previous studies indicated ATRA could lead to leukemia m
Some types of acute myeloid leukemia (AML) can be treated with all-trans retinoic acid (ATRA), which induces cell differentiation, in combination with other chemotherapeutics. However, previous studies indicated ATRA could lead to leukemia m
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/as8377
Autor:
Shu-RuYang, 楊淑如
102
Platelets are produced from megakaryocyte fragmentation which is crucial for blood coagulation. When hematopoietic stem cells differentiate into megakaryocytes, reactive oxygen species (ROS) and autophagy are essential. On the other hand, en
Platelets are produced from megakaryocyte fragmentation which is crucial for blood coagulation. When hematopoietic stem cells differentiate into megakaryocytes, reactive oxygen species (ROS) and autophagy are essential. On the other hand, en
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/955m89
102
Acute myeloid leukemia (AML) is a general boold disease in adults, there are over two hundred and fifty thousand of adults were diagnosed with AML over the world each year. Studies have revealed that PI3K/AKT/mTOR pathway continued to be act
Acute myeloid leukemia (AML) is a general boold disease in adults, there are over two hundred and fifty thousand of adults were diagnosed with AML over the world each year. Studies have revealed that PI3K/AKT/mTOR pathway continued to be act
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/24306196413758932801